Savana is an international medical company that has developed a scientific methodology applying Artificial Intelligence (AI) to unlock the clinical value within Electronic Health Records' free-text (EHRs). Founded in 2014, the company has built the largest AI-enabled, multi-language, multi-center research network globally. Savana's technology generates customized descriptive and predictive, High-quality Deep Real World Evidence research studies. The company, headquartered in Spain, prides itself on engineering their solutions following the highest privacy-by-design standards. Savana's ecosystem seeks to advance personalized and precision medicine. The company recently secured a $25.00M Venture Round investment on 5th April 2022, with notable backers such as Cathay Innovation, Conexo Ventures, Knuru Capital, Seaya Ventures, and Aldea Ventures.
No recent news or press coverage available for Savana.